BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy. Front Microbiol 2018;9:2603. [PMID: 30425706 DOI: 10.3389/fmicb.2018.02603] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Peruhype-magalhães V, de Araújo FF, de Morais Papini TF, Wendling APB, Campi-azevedo AC, Coelho-dos-reis JG, de Almeida IN, do Valle Antonnelli LR, Amaral LR, de Souza Gomes M, Brito-de-sousa JP, Elói-santos SM, Augusto VM, Pretti Dalcolmo MM, Carneiro CM, Teixeira-carvalho A, Martins-filho OA. Serum biomarkers in patients with unilateral or bilateral active pulmonary tuberculosis: Immunological networks and promising diagnostic applications. Cytokine 2023;162:156076. [DOI: 10.1016/j.cyto.2022.156076] [Reference Citation Analysis]
2 Sitoe N, Ahmed M, Enosse M, Bakuli A, Chissumba R, Held K, Hoelscher M, Nhassengo P, Khosa C, Rachow A, Geldmacher C; on behalf of TB Sequel Consortium. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status. Pathogens 2022;11:1034. [DOI: 10.3390/pathogens11091034] [Reference Citation Analysis]
3 Messah ADV, Nugroho CMH, Kurnia RS, Silaen OSM, Darmiati S, Rumende CM, Soemarwoto RA, Prihartono J, Asmarinah A. Correlation Between Gene Polymorphisms and Levels of Serum Matrix Metalloproteinases with Cavitary Features and Pulmonary Fibrosis of the Patient Tuberculosis Multi-Drug Resistance Using High-Resolution Computerized Tomography of the Thorax.. [DOI: 10.21203/rs.3.rs-1996763/v1] [Reference Citation Analysis]
4 Kathamuthu GR, Bhavani PK, Singh M, Saini JK, Aggarwal A, Ansari MSS, Garg R, Babu S. High-Dose Rifampicin Mediated Systemic Alterations of Cytokines, Chemokines, Growth Factors, Microbial Translocation Markers, and Acute-Phase Proteins in Pulmonary Tuberculosis. Front Pharmacol 2022;13:896551. [DOI: 10.3389/fphar.2022.896551] [Reference Citation Analysis]
5 Bresser PL, Reed J, Sathekge MM, Vorster M. 68 Ga-nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series. J Med Radiat Sci 2022. [PMID: 35760568 DOI: 10.1002/jmrs.603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shimoda M, Yoshiyama T, Okumura M, Tanaka Y, Morimoto K, Kokutou H, Osawa T, Furuuchi K, Fujiwara K, Ito K, Yoshimori K, Ohta K. Analysis of risk factors for pulmonary tuberculosis with persistent severe inflammation: An observational study. Medicine (Baltimore) 2022;101:e29297. [PMID: 35583541 DOI: 10.1097/MD.0000000000029297] [Reference Citation Analysis]
7 Zhou Y, Zhang F, Ding J. As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases. Immune Netw 2022;22:e21. [DOI: 10.4110/in.2022.22.e21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kay AW, Rabie H, Maleche-Obimbo E, Sekadde MP, Cotton MF, Mandalakas AM. HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies. Pathogens 2021;11:33. [PMID: 35055981 DOI: 10.3390/pathogens11010033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hayford FEA, Dolman RC, Ozturk M, Nienaber A, Ricci C, Loots DT, Brombacher F, Blaauw R, Smuts CM, Parihar SP, Malan L. Adjunct n-3 Long-Chain Polyunsaturated Fatty Acid Treatment in Tuberculosis Reduces Inflammation and Improves Anemia of Infection More in C3HeB/FeJ Mice With Low n-3 Fatty Acid Status Than Sufficient n-3 Fatty Acid Status. Front Nutr 2021;8:695452. [PMID: 34504860 DOI: 10.3389/fnut.2021.695452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Linge IA, Apt AS. A controversial role of neutrophils in tuberculosis infection pathogenesis. Russian Journal of Infection and Immunity 2021;11:809-819. [DOI: 10.15789/2220-7619-acr-1670] [Reference Citation Analysis]
11 Noschka R, Wondany F, Kizilsavas G, Weil T, Weidinger G, Walther P, Michaelis J, Stenger S. Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis. Int J Mol Sci 2021;22:8392. [PMID: 34445098 DOI: 10.3390/ijms22168392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kathamuthu GR, Moideen K, Thiruvengadam K, Sridhar R, Baskaran D, Babu S. Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis. Front Cell Infect Microbiol 2021;11:680665. [PMID: 34350132 DOI: 10.3389/fcimb.2021.680665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Jøntvedt Jørgensen M, Nore KG, Aass HCD, Layre E, Nigou J, Mortensen R, Tasken K, Kvale D, Jenum S, Tonby K, Dyrhol-Riise AM. Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients. Front Cell Infect Microbiol 2021;11:669623. [PMID: 34307194 DOI: 10.3389/fcimb.2021.669623] [Reference Citation Analysis]
14 Mortimer K, Nantanda R, Meghji J, Vanker A, Bush A, Ndimande N, Ozoh O, Masekela R. Africa’s respiratory “Big Five”. JPATS 2021;2:64-72. [DOI: 10.25259/jpats_12_2021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Druszczynska M, Seweryn M, Wawrocki S, Kowalewska-Pietrzak M, Pankowska A, Rudnicka W. Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children. Pathogens 2021;10:517. [PMID: 33923293 DOI: 10.3390/pathogens10050517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nienaber A, Hayford FEA, Variava E, Martinson N, Malan L. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis. Front Immunol 2021;12:623941. [PMID: 33777003 DOI: 10.3389/fimmu.2021.623941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kumar NP, Kathamuthu GR, Moideen K, Banurekha VV, Nair D, Fay MP, Nutman TB, Babu S. Strongyloides stercoralis Coinfection Is Associated With Greater Disease Severity, Higher Bacterial Burden, and Elevated Plasma Matrix Metalloproteinases in Pulmonary Tuberculosis. J Infect Dis 2020;222:1021-6. [PMID: 32307511 DOI: 10.1093/infdis/jiaa194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
18 Gill LI, Dominic C, Tiberi S. Atypical mycobacterial infections - management and when to treat. Curr Opin Pulm Med 2021;27:216-23. [PMID: 33560672 DOI: 10.1097/MCP.0000000000000764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Febriana A, Olivianto E, Khotimah H. The role of tumor necrosis factor-α and Interleukin-17 with severity of lung damage in paediatric tuberculosis. INTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020) 2021. [DOI: 10.1063/5.0052772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ignatius EH, Dooley KE. Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis. Advances in Host-Directed Therapies Against Tuberculosis 2021. [DOI: 10.1007/978-3-030-56905-1_22] [Reference Citation Analysis]
21 Meghji J, Brown J, Lipman M. Post-Tuberculosis Infections and Chronic Lung Disease. Essential Tuberculosis 2021. [DOI: 10.1007/978-3-030-66703-0_32] [Reference Citation Analysis]
22 Arbués A, Kammüller M, Portevin D. Generating Three-dimensional Human Granulomas in vitro to Study Mycobacterium tuberculosis-Host Interaction. Bio Protoc 2020;10:e3820. [PMID: 33659472 DOI: 10.21769/BioProtoc.3820] [Reference Citation Analysis]
23 Minomo S, Kobayashi T, Katayama K, Ryuge M, Kagawa T, Tsuyuguchi K, Matsui H, Suzuki K. Risk factors for hemoptysis in Mycobacterium avium complex lung disease. Respir Investig 2021;59:218-22. [PMID: 33069662 DOI: 10.1016/j.resinv.2020.09.007] [Reference Citation Analysis]
24 Hayford FEA, Dolman RC, Blaauw R, Nienaber A, Smuts CM, Malan L, Ricci C. The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis. Respir Res 2020;21:223. [PMID: 32847532 DOI: 10.1186/s12931-020-01488-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
25 Shete A, Bichare S, Pujari V, Virkar R, Thakar M, Ghate M, Patil S, Vyakarnam A, Gangakhedkar R, Bai G, Niki T, Hattori T. Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals. Front Microbiol 2020;11:1685. [PMID: 32765475 DOI: 10.3389/fmicb.2020.01685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Amaral EP, Vinhaes CL, Oliveira-de-Souza D, Nogueira B, Akrami KM, Andrade BB. The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis. Antioxid Redox Signal 2021;34:471-85. [PMID: 32559410 DOI: 10.1089/ars.2020.8124] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
27 Wei M, Yongjie Zhao, Zhuoyu Qian, Biao Yang, Xi J, Wei J, Tang B. Pneumonia caused by Mycobacterium tuberculosis. Microbes Infect 2020;22:278-84. [PMID: 32561408 DOI: 10.1016/j.micinf.2020.05.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
28 Muefong CN, Sutherland JS. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology. Front Immunol 2020;11:962. [PMID: 32536917 DOI: 10.3389/fimmu.2020.00962] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
29 Khosa C, Bhatt N, Massango I, Azam K, Saathoff E, Bakuli A, Riess F, Ivanova O, Hoelscher M, Rachow A. Development of chronic lung impairment in Mozambican TB patients and associated risks. BMC Pulm Med 2020;20:127. [PMID: 32381002 DOI: 10.1186/s12890-020-1167-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
30 Fernández-García M, Rey-Stolle F, Boccard J, Reddy VP, García A, Cumming BM, Steyn AJC, Rudaz S, Barbas C. Comprehensive Examination of the Mouse Lung Metabolome Following Mycobacterium tuberculosis Infection Using a Multiplatform Mass Spectrometry Approach. J Proteome Res 2020;19:2053-70. [PMID: 32285670 DOI: 10.1021/acs.jproteome.9b00868] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
31 Kochuieva M, Hrek I, Klimova O, Rogozhyn A, Kushnir V. IMMUNE STATUS OF PATIENTS WITH LUNG TUBERCULOSIS AND ALCOHOL CONSUMPTION. EUREKA: Health Sciences 2020;2:8-16. [DOI: 10.21303/2504-5679.2020.001177] [Reference Citation Analysis]
32 Stek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F, Lombard A, Wilkinson RJ, Meintjes G, Lynen L. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function. Eur Respir J 2020;55:1901692. [PMID: 31862762 DOI: 10.1183/13993003.01692-2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kathamuthu GR, Kumar NP, Moideen K, Nair D, Banurekha VV, Sridhar R, Baskaran D, Babu S. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis. Front Immunol 2020;11:419. [PMID: 32218787 DOI: 10.3389/fimmu.2020.00419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
34 Mashabela GT, Wet TJD, Warner DF. Mycobacterium tuberculosisMetabolism. Gram-Positive Pathogens 2019. [DOI: 10.1128/9781683670131.ch67] [Reference Citation Analysis]
35 Golubinskaya E, Filonenko T, Kramar T, Yermola Y, Kubyshkin A, Gerashenko A, Kalfa M, Shramko I. Dysregulation of VEGF-dependent angiogenesis in cavernous lung tuberculosis. Pathophysiology 2019;26:381-7. [DOI: 10.1016/j.pathophys.2019.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Bai G, Matsuba T, Kikuchi H, Chagan-Yasutan H, Motoda H, Ozuru R, Yamada O, Oshima Y, Hattori T. Inhibition of inflammatory-molecule synthesis in THP-1 cells stimulated with phorbol 12-myristate 13-acetate by brefelamide derivatives. Int Immunopharmacol 2019;75:105831. [PMID: 31437790 DOI: 10.1016/j.intimp.2019.105831] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Mashabela GT, de Wet TJ, Warner DF, Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Braunstein M, Rood JI. Mycobacterium tuberculosis Metabolism. Microbiol Spectr 2019;7. [DOI: 10.1128/microbiolspec.gpp3-0067-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
38 Dheda K. Improving outcomes in patients with non-tuberculous mycobacterial disease: is there light at the end of the tunnel? Eur Respir J 2019;54:1901149. [DOI: 10.1183/13993003.01149-2019] [Reference Citation Analysis]
39 Kumar NP, Moideen K, Banurekha VV, Nair D, Babu S. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. Open Forum Infect Dis 2019;6:ofz257. [PMID: 31281858 DOI: 10.1093/ofid/ofz257] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
40 Rohlwink UK, Walker NF, Ordonez AA, Li YJ, Tucker EW, Elkington PT, Wilkinson RJ, Wilkinson KA. Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis-A Review. Int J Mol Sci 2019;20:E1350. [PMID: 30889803 DOI: 10.3390/ijms20061350] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
41 Riou C, Stek C, Du Bruyn E. Immune Responses to Mycobacterium tuberculosis and the Impact of HIV Infection. HIV and Tuberculosis 2019. [DOI: 10.1007/978-3-030-29108-2_4] [Reference Citation Analysis]